DD294255A5 - PROCESS FOR PREPARING TETRAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES - Google Patents
PROCESS FOR PREPARING TETRAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES Download PDFInfo
- Publication number
- DD294255A5 DD294255A5 DD34061090A DD34061090A DD294255A5 DD 294255 A5 DD294255 A5 DD 294255A5 DD 34061090 A DD34061090 A DD 34061090A DD 34061090 A DD34061090 A DD 34061090A DD 294255 A5 DD294255 A5 DD 294255A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- aryl radical
- phenyl
- alkyl
- chem
- Prior art date
Links
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title claims abstract 9
- 238000004519 manufacturing process Methods 0.000 title claims 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 60
- -1 carbonyl halides Chemical class 0.000 claims abstract description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000543 intermediate Substances 0.000 claims abstract description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 6
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims abstract description 5
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011541 reaction mixture Substances 0.000 claims abstract description 5
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 4
- 150000003230 pyrimidines Chemical class 0.000 claims abstract 7
- 238000000034 method Methods 0.000 claims abstract 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract 3
- 230000015572 biosynthetic process Effects 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 3
- 238000002360 preparation method Methods 0.000 claims abstract 3
- 239000011734 sodium Substances 0.000 claims abstract 3
- 229910052708 sodium Inorganic materials 0.000 claims abstract 3
- 238000003786 synthesis reaction Methods 0.000 claims abstract 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 150000005840 aryl radicals Chemical class 0.000 claims 13
- 125000003277 amino group Chemical group 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 244000309464 bull Species 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- MNMJCSGSYVIWHT-UHFFFAOYSA-N 2-oxo-1h-pyrimidine-6-carbonitrile Chemical class O=C1N=C(C#N)C=CN1 MNMJCSGSYVIWHT-UHFFFAOYSA-N 0.000 claims 1
- 240000003450 Mallotus philippensis Species 0.000 claims 1
- 150000001409 amidines Chemical class 0.000 claims 1
- UAZDIGCOBKKMPU-UHFFFAOYSA-O azanium;azide Chemical compound [NH4+].[N-]=[N+]=[N-] UAZDIGCOBKKMPU-UHFFFAOYSA-O 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 1
- 239000009355 kamala Substances 0.000 claims 1
- QBRCMHSAOZCHQH-UHFFFAOYSA-N n-pyrimidin-2-ylbenzamide Chemical class C=1C=CC=CC=1C(=O)NC1=NC=CC=N1 QBRCMHSAOZCHQH-UHFFFAOYSA-N 0.000 claims 1
- IIHQNAXFIODVDU-UHFFFAOYSA-N pyrimidine-2-carbonitrile Chemical class N#CC1=NC=CC=N1 IIHQNAXFIODVDU-UHFFFAOYSA-N 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- ZGYRTJADPPDDMY-UHFFFAOYSA-N titanium;tetrahydrate Chemical compound O.O.O.O.[Ti] ZGYRTJADPPDDMY-UHFFFAOYSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
- 239000013078 crystal Substances 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 6
- 239000012346 acetyl chloride Substances 0.000 description 6
- 238000003760 magnetic stirring Methods 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 4
- ZZTURJAZCMUWEP-UHFFFAOYSA-N diaminomethylideneazanium;hydrogen sulfate Chemical compound NC(N)=N.OS(O)(=O)=O ZZTURJAZCMUWEP-UHFFFAOYSA-N 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- YSIJXBPCNIAXEQ-UHFFFAOYSA-N n,n-dimethyl-2-(1-phenyltetrazol-5-yl)ethenamine Chemical compound CN(C)C=CC1=NN=NN1C1=CC=CC=C1 YSIJXBPCNIAXEQ-UHFFFAOYSA-N 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- XPOLVIIHTDKJRY-UHFFFAOYSA-N acetic acid;methanimidamide Chemical compound NC=N.CC(O)=O XPOLVIIHTDKJRY-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical compound Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- JEZPNFLAXIIAMB-UHFFFAOYSA-N 2-[1-(4-chlorophenyl)tetrazol-5-yl]-n,n-dimethylethenamine Chemical compound CN(C)C=CC1=NN=NN1C1=CC=C(Cl)C=C1 JEZPNFLAXIIAMB-UHFFFAOYSA-N 0.000 description 1
- AIRNIEMEWFLMQM-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-(1-phenyltetrazol-5-yl)pyrimidin-2-amine Chemical compound C=1C=CC(Cl)=CC=1C1=NC(N)=NC=C1C1=NN=NN1C1=CC=CC=C1 AIRNIEMEWFLMQM-UHFFFAOYSA-N 0.000 description 1
- RUSPQQSAANBVRS-UHFFFAOYSA-N 4-ethyl-5-(1-phenyltetrazol-5-yl)pyrimidin-2-amine Chemical compound CCC1=NC(N)=NC=C1C1=NN=NN1C1=CC=CC=C1 RUSPQQSAANBVRS-UHFFFAOYSA-N 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- RGMXHRFXVQVUQW-UHFFFAOYSA-N 5-[1-(4-methoxyphenyl)tetrazol-5-yl]-4-phenylpyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1N1C(C=2C(=NC(N)=NC=2)C=2C=CC=CC=2)=NN=N1 RGMXHRFXVQVUQW-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LZCZIHQBSCVGRD-UHFFFAOYSA-N benzenecarboximidamide;hydron;chloride Chemical compound [Cl-].NC(=[NH2+])C1=CC=CC=C1 LZCZIHQBSCVGRD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- SSWJWJCISJSIKK-UHFFFAOYSA-N n,n-dimethyl-2-[1-(4-methylphenyl)tetrazol-5-yl]ethenamine Chemical compound CN(C)C=CC1=NN=NN1C1=CC=C(C)C=C1 SSWJWJCISJSIKK-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die Erfindung beschreibt ein Verfahren zur Herstellung tetrazolylsubstituierter Pyrimidinderivate. Heterocyclen dieses Typs sind als Zwischenprodukte zur Synthese biologisch aktiver Verbindungen von Interesse. Die Titelverbindungen werden erfindungsgemaesz hergestellt, indem man * (Formel I) in Loesungsmitteln wie Acetonitril oder Benzen mit Carbonsaeurehalogeniden (Formel II) in Gegenwart aequimolarer Mengen einer Hilfsbase wie Pyridin oder Triethylamin bei Temperaturen bis zum Siedepunkt des Reaktionsgemisches umsetzt und die hierbei gebildeten * (Formel III) mit Guanidin (Formel IV, R3NH2) oder Carbonsaeureamidinen (Formel IV, R3H, Alkyl, Aryl) in siedender alkoholischer Loesung in Gegenwart eines basischen Kondensationsmittels, z. B. Natriumalkoholat, zur Reaktion bringt.{Pyrimidinderivate; * Zwischenprodukte; * Carbonsaeurehalogenide; Pyridin; Triethylamin; * Guanidin; Carbonsaeureamidine; Natriumalkoholat}The invention describes a process for the preparation of tetrazolyl-substituted pyrimidine derivatives. Heterocycles of this type are of interest as intermediates for the synthesis of biologically active compounds. The title compounds are prepared according to the invention by reacting * (formula I) in solvents such as acetonitrile or benzene with carbonyl halides (formula II) in the presence of equimolar amounts of an auxiliary base such as pyridine or triethylamine at temperatures up to the boiling point of the reaction mixture and the * (formula III) with guanidine (formula IV, R3NH2) or Carbonsaeureamidinen (formula IV, R3H, alkyl, aryl) in boiling alcoholic solution in the presence of a basic condensing agent, eg. As sodium alcoholate, brings to the reaction {Pyrimidinderivate; * Intermediates; * Carboxylic acid halides; pyridine; triethylamine; * Guanidine; Carbonsaeureamidine; sodium alcoholate}
Description
bedeuten, in Gegenwart äquimolarer Mengen einer Hilfsbase wie Pyridin oder Triethylamin bei Temperaturen bis zum Siedepunkt des Reaktionsgemisches umseut und die hierbei gebildeten 1-ary!substituierten 5-(1-Acyl-2-d!methylamino-vinyl)-1 H-tetrazole III mit Guanidin (Formel IV, R3 = NH2) oder Carbonsäureamiden (Formel IV, R3 = H, Alkyl oder Aryl) in siedender alkoholischer (z. B. methanolischer oder ethanolischer) Lösung in Gegenwart eines basischen Kondensationsmittels, z. B. Natriummethanolat oder Natriumethanolat, zur Reaktion bringt. Die Zwischenprodukte III fallen beim Einengen des Reaktionsgemisches in fester kristalliner Form zusammen mit dem Hydrohalogenid der Hilfsbase an und werden von diesem durch Waschen mit Wasser befreit. Die Reaktionskomponenten IV (R3 = NH2, H, Alkyl, Aryl) können in Form ihrer jagerstabilen Salze (z.B. Hydrosulfate, Hydrochloride u.a.) verwendet und im Reaktionsgemisch durch einen entsprechenden Überschuß ah basischem Kondensationsmittel freigesetzt werden.mean in the presence of equimolar amounts of an auxiliary base such as pyridine or triethylamine at temperatures up to the boiling point of the reaction mixture umseut and the resulting 1-ary! substituted 5- (1-acyl-2-d! methylamino-vinyl) -1H-tetrazoles III with guanidine (formula IV, R 3 = NH 2 ) or carboxylic acid amides (formula IV, R 3 = H, alkyl or aryl) in boiling alcoholic (eg methanolic or ethanolic) solution in the presence of a basic condensing agent, e.g. As sodium methoxide or sodium ethoxide, brings to the reaction. The intermediates III are obtained on concentration of the reaction mixture in solid crystalline form together with the hydrohalide of the auxiliary base and are freed from this by washing with water. The reaction components IV (R 3 = NH 2 , H, alkyl, aryl) can be used in the form of their chelator-stable salts (eg hydrosulfates, hydrochlorides, etc.) and released in the reaction mixture by a corresponding excess ah basic condensing agent.
Die Ausgangsverbindungen I sind durch Umsetzung von 3-Halogen-prop-2-en-1-ylidendimethyliminiumsalzen mit überschüssigem Natriumazid in alkoholischer Lösung leicht zugänglich (DD 268690; vgl. G.W. FISCHER und M. HERRMANN, J. prakt. Chem. 330 [1988] 963).The starting compounds I are readily accessible by reaction of 3-halo-prop-2-en-1-ylidenedimethyliminium salts with excess sodium azide in alcoholic solution (DD 268690, compare GW FISCHER and M. HERRMANN, J. prakt. Chem ] 963).
Die Erfindung wird nachstehend an 8 Ausführungsbetspielen erläutort; die hierin angegebenen Ausbeuten an V beziehen sich auf die eingesetzten 1-Aryl-5-(2-dlmethylamino-vinyl)-1 H-tetrazole I.The invention will be explained below with reference to 8 embodiments; the yields of V given herein are based on the 1-aryl-5- (2-dimethylamino-vinyl) -1H-tetrazoles I.
2-Amino-4-methyl-5-(1-phenyl-1H-tetrazol-5-yl)-pyrimidin (V, R1 = Ph, R7 = Me,R3 = NH2)2-amino-4-methyl-5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = Ph, R 7 = Me, R 3 = NH 2 )
0,95g (12mmol) trockenem Pyridin wird mit 0,94g (12mmol) Acetylchlorid (II, R2 = Me, X = Cl) versetzt und unter0.95 g (12 mmol) of dry pyridine is mixed with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) and under
digeriert den verbleibenden Rückstand mit Wasser, saugt ab, wäscht mit Wasser und trocknet über PjO6. Das so erhaltenedigested the remaining residue with water, filtered off with suction, washed with water and dried over PjO 6 . The thus obtained
20 ml einer 1N ethanolischen Natriumethanolatlösung 3 Std. unter magnetischem Rühren rückfließend erhitzt, wobei sich das20 ml of a 1N ethanolic sodium ethanolate refluxing 3 hr. With magnetic stirring, the
2-Amino-4-methyl-5-[1-(4-methyl-phenyl)-1H-tetrazol-5-yl]-pyrimidin (V, R1 = 4-Me-C6H4, R2 = Me, R3 = NH2) Ausbeute 83%. Farblose Kristalle (aus Acetonitril), Schmp. 225-2260C.2-Amino-4-methyl-5- [1- (4-methyl-phenyl) -1H-tetrazol-5-yl] -pyrimidine (V, R 1 = 4-Me-C 6 H 4 , R 2 = Me , R 3 = NH 2 ) Yield 83%. Colorless crystals (from acetonitrile), mp. 225-226 0 C.
2-Amino-5-[1-(4-ethyl-phenyl)-1H-tetrazol-5-yl)-4-methyl-pyrimidin (V, R1 = 4-Et-CeH4, R2 = Me, R3 = NH2) Ausbeute 75%. Farblose Blättchen (aus Ethanol), Schmp. 197-1980C.2-Amino-5- [1- (4-ethyl-phenyl) -1H-tetrazol-5-yl) -4-methylpyrimidine (V, R 1 = 4-Et-C e H 4 , R 2 = Me , R 3 = NH 2 ) Yield 75%. Colorless platelets (from ethanol), mp 197-198 0 C.
2-Amino-6-H-(4-methoxy-phenyl)-1 H-tetrazol-5-yl]-4-methyl-pyrim!din (V, R1 = 4-MeO-C„H4, R2 = Me, R3 = NH2) Ausbeute 89%. Farblose Kristalle (aus Ethanol), Schmp. 193-1940C.2-Amino-6-H- (4-methoxyphenyl) -1H-tetrazol-5-yl] -4-methyl-pyrimidine (V, R 1 = 4-MeO-C "H 4 , R 2 = Me, R 3 = NH 2 ) Yield 89%. Colorless crystals (from ethanol), mp 193-194 0 C.
2-Amino-5-I1-(4-fluor-phenyl)-1H-tetrazol·5-yl]-4-methyl-pyrimidln (V, R1 = 4-F-CeH4, R2 = Me, R3 = NH2) Ausbeute 79%. Farblose Blättchen (aus Acetonitril), Schmp. 225-2260C.2-Amino-5-I1- (4-fluoro-phenyl) -1H-tetrazol-5-yl] -4-methyl-pyrimidine (V, R 1 = 4-FC e H 4 , R 2 = Me, R 3 = NH 2 ) yield 79%. Colorless flake (from acetonitrile), mp. 225-226 0 C.
2-Amino-5-[1-(4-chlor-phenyl)-1H-tetrazol-5-yll-4-methyl-pyrimidin (V, R1 = 4-CI-CeH4, R2 = Me, R3 = NH2) Ausbeute 77%. Farblose Blättchen (aus Acetonitril), Schmp. 251-2520C (Zers.).2-Amino-5- [1- (4-chloro-phenyl) -1H-tetrazol-5-yl-4-methylpyrimidine (V, R 1 = 4-Cl-CeH 4 , R 2 = Me, R 3 = NH 2 ) yield 77%. Colorless leaves (from acetonitrile), mp 251-252 0 C (dec.).
2-Amino-5-[1-(4-brom-phenyl)-1H-tetrazol-5-yll-4-methyl-pyrimidin (V, R1 = 4-Br-C8H4, R2 = Me, R3 = NH2) Ausbeute 83%. Farblose Blättchen (aus Dioxan), Schmp. 257-2580C (Zers.)2-amino-5- [1- (4-bromo-phenyl) -1H-tetrazol-5-yl-4-methylpyrimidine (V, R 1 = 4-Br-C 8 H 4 , R 2 = Me, R 3 = NH 2 ) Yield 83%. Colorless Leaflets (made of Dioxane), m.p. 257-258 0 C (Zers.)
2-Amino-5-(1-(4-iod-phenyl)-1H-tetrazol-5-yl|-4-methyl-pyrimldin (V, R' = 4^C4H4, R2 = Me, R3 = NH2) Ausbeute 86%. Farblose Blättchen (aus Dioxan), Schmp. 256-2570C (Zers.).2-Amino-5- (1- (4-iodo-phenyl) -1H-tetrazol-5-yl-4-methyl-pyrimidine (V, R '= 4 C 4 H 4 , R 2 = Me, R 3 = NH 2 ) Yield 86% Colorless flakes (from dioxane), mp 256-257 0 C (dec.).
2.Amlno-5-l1-(4-biphenylyl)-1H-tetrazol-5-yll-4-methyl-pyrimidln (V, R1 - 4-Ph-C9H4, R2 = Me, R3 = NH2) Ausbeute 70%. Farblose Kristalle (aus Dioxan), Schmp. 222-2230C2. Amlno-5-l1- (4-biphenylyl) -1H-tetrazol-5-yl-4-methyl-pyrimidine (V, R 1 -4-Ph-C 9 H 4 , R 2 = Me, R 3 = NH 2 ) yield 70%. Colorless crystals (from dioxane), mp 222-223 0 C
2-Amlno-4-ethyl-5-(1-phenyl-1H-tetrazol-5-yl)-pyrimldln (V, R1 = Ph, R2 = Et, R3 = NH2) Ausbeute 81 %. Farblose Kristalle (aus Methanol), Schmp. 170-1710C.2-Amino-4-ethyl-5- (1-phenyl-1H-tetrazol-5-yl) pyrimidine (V, R 1 = Ph, R 2 = Et, R 3 = NH 2 ) Yield 81%. Colorless crystals (from methanol); mp. 170-171 0 C.
2-Amino-2-ethyl-5-|1-(4-methyl-phenyl)-1H-tetrazol-5-yl)-pyrimldin (V, R* = 4-Me-CgH4, R2 = Et, R3 = NH2) Ausbeute 90%. Farblose Kristalle (aus Methanol), Schmp. 157-1580C2-Amino-2-ethyl-5- | 1- (4-methylphenyl) -1H-tetrazol-5-yl) -pyrimidine (V, R * = 4-Me-CgH 4 , R 2 = Et, R 3 = NH 2 ) Yield 90%. Colorless crystals (from methanol), mp 157-158 0 C
2-ΑΓηίηο-5-(1-ρηβηγΜΗ·ΙβΐΓ8ζοΙ-5-γΙ)·4·ρΓοργΙ·ρνΓίπιΙα1η (V, R1 - Ph, R2 = Pr11R3 = NH2) Ausbeute 88%. Farblose Kristalle (aus Methanol), Schmp. 132-1330C.2-ΑΓηίηο-5- (1-ρηβηγΜΗ · ΙβΐΓ8ζοΙ-5-γΙ) · 4 · ρΓοργΙ · ρνΓίπιΙα1η (V, R 1 - Ph, R 2 = Pr 11 R 3 = NH 2 ) Yield 88%. Colorless crystals (from methanol); mp. 132-133 0 C.
2^Ιηο-5-[1-(4^βΙηνΙ·ρηβηνΙ)-1Η-ΙβΐΓβζοΙ·5-νΙ)-4-ρΓθρνΙ-ρνΜπ^Ιη (V, R1 = 4-Me-C,H4, R2 = Pr, R3 = NH2) Ausbeute 86%. Farblose Kristalle (aus Methanol), Schmp. 180-1810C.2 ^ Ιηο-5- [1- (4ββΙηνΙ · ρηβηνΙ) -1Η-ΙβΐΓβζοΙ · 5-νΙ) -4-ρΓθρνΙ-ρνΜπ ^ Ιη (V, R 1 = 4-Me-C, H 4 , R 2 = Pr, R 3 = NH 2 ) yield 86%. Colorless crystals (from methanol); mp. 180-181 0 C.
2-Amino-4-phenyl-5-(1-phenyM H-tetrazol-5-yl)-pyrimldin (V, R1 = R2 = Ph, R3 = NH2)2-amino-4-phenyl-5- (1-phenyl-H-tetrazol-5-yl) -pyrimidine (V, R 1 = R 2 = Ph, R 3 = NH 2 )
2,15g (lOmmol) 5-(2-Dlmethylamino-vlnyl)-1 -phenyl-1 H-tetrazol (I, R' = Ph) werden in 10ml absol. Benzen mit 1,21 g (12mmol)2.15 g (10 mmol) of 5- (2-dimethylaminophenyl) -1-phenyl-1H-tetrazole (I, R '= Ph) are dissolved in 10 ml of absolute. Benzen with 1.21 g (12mmol)
wasserfreiem Triethylamin und 1,69g (12mmol) Benzoylchlorid (II, R2 = Ph, X = Cl) 4 Std. unter Feuchtigkeitsausschluß rückfließend erhitzt. Anschließend destilliert man die reichliche Hälfte des Lösungsmittels I. Vak. ab und läßt in der Kälte kristallisieren. Das Kristallgemisch wird abgesaugt, durch Waschen mit Wasser von Triethylaminhydrochlorid befreit und getrocknet. Das so erhaltene Zwischenprodukt III (R' = R2 = Ph) wird zusammen mit 2,25g (lOmmol) Guanidinsulfat (2IV · H2SO4 · 0,5 H2O, R3 = NH2) in 20 ml einer 1N methanolischen Natriummethanolatlösung 4 Std. unter magnetischemanhydrous triethylamine and 1.69 g (12 mmol) of benzoyl chloride (II, R 2 = Ph, X = Cl) refluxing for 4 hours with exclusion of moisture. Then distilled the plentiful half of the solvent I. Vak. and lets crystallize in the cold. The crystal mixture is filtered off with suction, freed from triethylamine hydrochloride by washing with water and dried. The resulting intermediate III (R '= R 2 = Ph) is combined with 2.25 g (10 mmol) guanidine sulfate (2IV.H 2 SO 4 .0.5 H 2 O, R 3 = NH 2 ) in 20 ml of 1N methanolic sodium methoxide solution 4 hours under magnetic
gewaschen und getrocknet. Ausbeute 2,50g (79%); farblose Blättchen (aus Dioxan), Schmp. 267-2680C (Zers.).washed and dried. Yield 2.50 g (79%); colorless platelets (made of dioxane), mp 267-268 0 C (Zers.).
2-Amino-5-H-(4-methyl-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrimidin (V, R1 = 4-Me-C8H4, R2 = Ph, R3« NH2)2-amino-5-H- (4-methylphenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimidine (V, R 1 = 4-Me-C 8 H 4 , R 2 = Ph, R 3 «NH 2 )
absol. Acetonitril und 0,95g (12mmol) trockenem Pyridin wird mit 1,69g (12mmol) Benzoylchlorid (II, R2 = Ph, X = Cl) versetzt und unter Feuchtigkeitsausschluß 3 Std. bei 8O0C auf dem Wasserbad erhitzt. Danach zieht man das Lösungsmittel i. Vak. ab, digeriert den Rückstand mit kaltem Wasser, saugt ab, wäscht mit Wasser und trocknet über P2Oe. Das so erhalteneabsol. Acetonitrile and 0.95 g (12 mmol) of dry pyridine is treated with 1.69 g (12 mmol) of benzoyl chloride (II, R 2 = Ph, X = Cl) and heated with exclusion of moisture for 3 hrs. At 8O 0 C on a water bath. Then draw the solvent i. Vak. The residue is digested with cold water, filtered off, washed with water and dried over P 2 Oe. The thus obtained
erstere langsam in Lösung geht und sich gleichzeitig das Endprodukt abzuscheiden beginnt. Nach dem Abkühlen saugt man ab, wäscht zuerst mit Ethanol, dann mehrmals mit Wasser und trocknet Ober P2O6. Ausbeute 2,88g (87%); farblose Blättchen (ausThe former slowly dissolves and at the same time the final product begins to separate. After cooling, the solution is filtered off with suction, washed first with ethanol, then several times with water and dried over P 2 O 6 . Yield 2.88g (87%); colorless leaves (out
2-Amino-5-l1-(4-ethyl-phenyl)-1H-tetrazol-5-yll-4-phenyl-pyrimidin (V, R1 = 4-Et-C6H4, R2 = Ph, R3 = NH2) Ausbeute 85%. Farblose Kristalle (aus Dioxan), Schmp. 244-2450C.2-Amino-5-l1- (4-ethyl-phenyl) -1H-tetrazol-5-yl-4-phenyl-pyrimidine (V, R 1 = 4-Et-C 6 H 4 , R 2 = Ph, R 3 = NH 2 ) yield 85%. Colorless crystals (from dioxane), mp 244-245 0 C.
2-Amino-5-[1-(4-methoxy-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrlmidin (V, R1 = 4-MeO-C6H4, R2 = Ph, R3 = NH2) Ausbeute 75%. Farblose Blättchen (aus Dioxan), Schmp. 246-2470C.2-Amino-5- [1- (4-methoxyphenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimidine (V, R 1 = 4-MeO-C 6 H 4 , R 2 = Ph , R 3 = NH 2 ) Yield 75%. Colorless leaflets (dioxane), mp 246-247 0 C.
2-Amino-5-[1-(4-fluor-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrimidin (V, R1 = 4-F-C6H4, R2 = Ph, R3 = NH2) Ausbeute 85%. Farblose Blättchen (aus Dioxan), Schmp. 274-2750C (Zers.).2-Amino-5- [1- (4-fluoro-phenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimidine (V, R 1 = 4-FC 6 H 4 , R 2 = Ph, R 3 = NH 2 ) yield 85%. Colorless leaflets (made of dioxane), mp 274-275 0 C (Zers.).
2-Amlno-5-(1-(4-chlor-phenyl)-1H-tetrazol-5-yll-4-phenyl-pyrimidin (V, R' = 4-CPC6H4, R2 = Ph, R3 = NH2) Ausbeute 90%. Farblose Kristalle (aus Dioxan), Schmp. 284-2850C (Zers.).2-Amino-5- (1- (4-chloro-phenyl) -1H-tetrazol-5-yl-4-phenyl-pyrimidine (V, R '= 4-CPC 6 H 4 , R 2 = Ph, R 3 = NH 2 ) Yield 90% Colorless crystals (from dioxane), mp 284-285 0 C (dec.).
2-Amino-5-|1-(4-brom-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrimidin (V, R1 = 4-Br-C6H4, R2 = Ph, R3 = NH2) Ausbeute 84%. Farblose Blättchen (aus Dioxan), Schmp. 285-2860C (Zers.)2-Amino-5- | 1- (4-bromo-phenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimidine (V, R 1 = 4-Br-C 6 H 4 , R 2 = Ph , R 3 = NH 2 ) Yield 84%. Colorless Leaflets (made of dioxane), m.p. 285-286 0 C (Zers.)
2-Amino-5-(1-(4-iod-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrimldin (V, R1 = 4-1-C6H4, R2 = Ph, R3 = NH2) Ausbeute 81 %. Farblose Kristalle (aus Dioxan), Schmp. 285-2860C (Zers.).2-amino-5- (1- (4-iodo-phenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimldin (V, R 1 = 4-1-C 6 H 4, R 2 = Ph , R 3 = NH 2 ) Yield 81% Colorless crystals (from dioxane), mp 285-286 0 C (dec.).
2-Amino-4-(3-fluor-phenyl)-5-(1-phenyl-1H-tetrazol-5-yl)-pyrimldln (V, R1 = Ph, R2 = 3-F-C6H4, R3 = NH2) Ausbeute 53%. Farblose Kristalle (aus Acetonitril), Schmp. 206-2070C.2-Amino-4- (3-fluoro-phenyl) -5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = Ph, R 2 = 3-FC 6 H 4 , R 3 = NH 2 ) Yield 53%. Colorless crystals (from acetonitrile), mp. 206-207 0 C.
2-Amino-4-(3-chlor-phenyl)-5-(1-phenyl-1H-tetrazol-5-yl)-pyrlmidin (V, R1 = Ph, R2 = 3-CI-C6H4, R3 = NH2) Ausbeute 82%. Farblose Kristalle (aus Acetonitril), Schmp. 208-2090C.2-Amino-4- (3-chlorophenyl) -5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = Ph, R 2 = 3-CI-C 6 H 4 , R 3 = NH 2 ) Yield 82%. Colorless crystals (from acetonitrile), mp 208-209 0 C.
2-Amino-4-(4-chlor-phenyl)-5-(1-phenyl-1H-tetrazol-5-yl)-pyrimidin (V, R1 = Ph, R2 = 4-CI-C6H4, R3 = NH2) Ausbeute 84%. Farblose Kristalle (aus Acetonitril), Schmp. 217-2180C.2-Amino-4- (4-chloro-phenyl) -5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = Ph, R 2 = 4-CI-C 6 H 4 , R 3 = NH 2 ) Yield 84%. Colorless crystals (from acetonitrile), mp. 217-218 0 C.
4-Methyl-5-(1-phenyl-1H-tetrazol-5-yl)-pyrlmidin (V, R1 = Ph, R2 = Me, R3 = H)4-methyl-5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = Ph, R 2 = Me, R 3 = H)
2,15g (lOmmol) 5-(2-Dimethylamino-vinyl)-1-phenyl-1H-tetrazol (I, R* = Ph) werden gemäß Beispiel 1 in 5ml absol. Acetonitril und 0,95g (12 mmol) trockenem Pyridin mit 0,94 g (12 mmol) Acetylchlorid (II, R2 = Me, X = Cl) zum Zwischenprodukt III, R1 = Ph,2.15 g (10 mmol) of 5- (2-dimethylamino-vinyl) -1-phenyl-1H-tetrazole (I, R * = Ph) are obtained according to Example 1 in 5 ml of absolute. Acetonitrile and 0.95 g (12 mmol) of dry pyridine with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) to the intermediate III, R 1 = Ph,
ethanoliecher Natriumethanolatlösung 3 Std. unter magnetischem Rühren am Rückfluß, destilliert dann 15 ml Ethanol ab und nimmt den Rückstand nach dem Abkühlen in Diethylether auf. Die organische Phase wird mehrmals mit Wasser gewaschen, mitEthanoliecher sodium ethanolate solution for 3 hours under magnetic stirring at reflux, then distilled off 15 ml of ethanol and the residue is taken up in diethyl ether after cooling. The organic phase is washed several times with water, with
5-H-(4-Methoxy-phenyl)-1H-tetrazol-5-yl)-4-methyl-pyrimidin (V, R1 = 4-MeO-C6H4, R2 = Me, R3 = H) 2,45g (lOmmol) 1-(4-Methoxy-phenyl)-5-(2-dimothylamino-vinyl)-1H-tetrazol (I, R* = 4-MeO-C6H4) werden gemäß Beispiel 1 in 5ml ebsol. Acetonitril und 0,95g (12mmol) trockenem Pyridin mit 0,94g (12mmol) Acetylchlorid (II, R2 = Me, X = Cl) zum5-H- (4-methoxy-phenyl) -1H-tetrazol-5-yl) -4-methyl-pyrimidine (V, R 1 = 4-MeO-C 6 H 4 , R 2 = Me, R 3 = H ) 2.45 g (10 mmol) of 1- (4-methoxy-phenyl) -5- (2-dimothylamino-vinyl) -1H-tetrazole (I, R * = 4-MeO-C 6 H 4 ) are obtained in accordance with Example 1 in 5ml ebsol. Acetonitrile and 0.95 g (12 mmol) of dry pyridine with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) for
5-(1-(4-Chlor-phenyl)-1H-tetrazol-5-yl]-4-methyl-pyrimidin (V, R1 = 4-CI-C6H4, R2 = Me, R3 = H) Ausbeute 60%. Farblose Kristalle (aus Methanol), Schmp. 133-1340C5- (1- (4-Chloro-phenyl) -1H-tetrazol-5-yl] -4-methyl-pyrimidine (V, R 1 = 4-CI-C 6 H 4 , R 2 = Me, R 3 = H) 60% yield. Colorless crystals (from methanol); mp. 133-134 0 C.
5-[1-(4-Brom-phenyl)-1H-tetrazol-5-yl)-4-methyl-pyrimldin (V, R1 = 4-Br-C6H4.. R2 - Me, R3 = H) Ausbeute 61 %. Farblose Kristalle (aus Methanol), Schmp. 153-1540C5- [1- (4-Bromo-phenyl) -1H-tetrazol-5-yl) -4-methyl-pyrimidine (V, R 1 = 4-Br-C 6 H 4 ... R 2 -Me, R 3 = H) Yield 61%. Colorless crystals (from methanol); mp. 153-154 0 C.
5-(1-(4-lod-phenyl)-1H-tetrazol-5-yll-4-methy|.pyrimldln (V, R1 = 4-1-C6H4, R2 = Me, R3 = H) Ausbeute 58%. Farblose Kristalle (aus Benzen), Schmp. 170-1710C5- (1- (4-iodo-phenyl) -1H-tetrazol-5-yll-4-methyl-| .pyrimldln (V, R 1 = 4-1-C 6 H 4, R 2 = Me, R 3 = H) 58% yield. Colorless crystals (from benzene), mp. 170-171 0 C.
4-Phenyl-5-(1 -phenyl·! H-tetrazol-5-yl)-pyrlmfdln (V, R1 = R2 = Ph, R3 = H) Ausbeute 69%. Farblose Kristalle (aus Methanol), Schmp. 121-1220C4-phenyl-5- (1-phenyl-!H-tetrazol-5-yl) -pyrylmagnolone (V, R 1 = R 2 = Ph, R 3 = H) Yield 69%. Colorless crystals (from methanol), mp 121-122 0 C
5-[1-(4-Methyl-phenyl)-1H-tetrazol-5-yl|-4-phenyl-pyrimidin (V, R1 - 4-Me-C6H4, R2 = Ph, R3 = H) Ausbeute 56%. Farblose Nadeln (aus Methanol), Schmp. 164-1650C.5- [1- (4-methyl-phenyl) -1H-tetrazol-5-yl | -4-phenyl-pyrimidine (V, R 1-4-Me-C 6 H 4, R 2 = Ph, R 3 = H) Yield 56%. Colorless needles (from methanol), mp 164-165 0 C.
5-[1-(4-Methoxy-phenyl)-1H-tetrazol-5-yl]-4-phenyl-pyrimidJn (V, R' = 4-MeO-C6H4, R2 = Ph, R3 = H) Ausbeute 82%. Farblose Kristalle (aus Methanol), Schmp. 128-1290C.5- [1- (4-methoxy-phenyl) -1H-tetrazol-5-yl] -4-phenyl-pyrimidJn (V, R '= 4-MeO-C 6 H 4, R 2 = Ph, R 3 = H) Yield 82%. Colorless crystals (from methanol); mp. 128-129 0 C.
2,4-Dimethyl-5-l1-(4-methyl-phenyl)-1H-tetrazol-5-yl]-pyrlmidin (V, R1 = 4-Me-C6H4, R2 = R3 = Me) 2,29g dOmmol) 5-(2-Dimethylamino-vinyl)-1-(4-methyl-phenyl)-1H-tetrazol (I, R1 = 4-Me-CjH4) werden gemäß Beispiel 1 in 5ml absol. Acetonitril und 0,95g (12mmol) trockenem Pyridin mit 0,94g (12mmol) Acetylchlorid (II, R2 = Me, X = Cl) zum2,4-dimethyl-5-l1- (4-methyl-phenyl) -1H-tetrazol-5-yl] -pyrimidine (V, R 1 = 4-Me-C 6 H 4 , R 2 = R 3 = Me ) 2.29 g dOmmol) 5- (2-dimethylamino-vinyl) -1- (4-methyl-phenyl) -1H-tetrazole (I, R 1 = 4-Me-CjH 4 ) are in accordance with Example 1 in 5ml absolute. Acetonitrile and 0.95 g (12 mmol) of dry pyridine with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) for
organische Phase mehrmals mit Wasser, trocknet mit Natriumsulfat und engt ein, wobei das Reaktionsprodukt langsam auskristallisiert. Ausbeute 1,82g (68%); farblose Kristalle (aus Diethylether), Schmp. 111-112°C.organic phase several times with water, dried with sodium sulfate and concentrated, the reaction product slowly crystallized. Yield 1.82g (68%); colorless crystals (from diethyl ether), mp. 111-112 ° C.
5-[H4-Chlor-phenyl)-1 H-tetrazol-5-yl]-2,4-dimethyl-pyrlmidin (V, R1 = 4-Cf-C8H4, R2 = R3 = Me) 2,50g dOmmol) 1-(4-Clor-phenyl)-5-(2-dimethylamino-vinyl)-1 H-tetrazol (I, R1 = 4-CI-CeH4) werden gemäß Beispiel 1 in 5ml absol. Acetonitril und 0,95g (12mmol) trockenem Pyridin mit 0,94g (12mmol) Acetylchlorid (II, R2 = Me,X = Cl) zum5- [H 4 -chlorophenyl] -1 H -tetrazol-5-yl] -2,4-dimethyl-pyrimidine (V, R 1 = 4-Cf-C 8 H 4 , R 2 = R 3 = Me) 2.50 g dOmmol) 1- (4-chlorophenyl) -5- (2-dimethylamino-vinyl) -1 H-tetrazole (I, R 1 = 4-CI-CeH 4 ) are in accordance with Example 1 in 5ml absol. Acetonitrile and 0.95 g (12 mmol) of dry pyridine with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) for
abgesaugt, zuerst mit wenig Ethanol, dann mehrmals mit Wasser gewaschen und getrocknet. Ausbeute 2,06g (72%); farblosefiltered off with suction, washed first with a little ethanol, then several times with water and dried. Yield 2.06 g (72%); colorless
5-[1-(4-Brom-phenyl)-1 H-tetrazol-5-yl]-2,4-dimethyl-pyrlmidin (V, R1 = 4-Br-C4H4, R2 = R3 = Me)5- [1- (4-Bromo-phenyl) -1H-tetrazol-5-yl] -2,4-dimethyl-pyrimidine (V, R 1 = 4-Br-C 4 H 4 , R 2 = R 3 = Me)
2-Mothyl-4-phenyl-5-(1-phenyl-1 H-tetrazol-5-yl)-pyrlmidin (V, R1 = R2 = Ph, R3 = Me)2-Mothyl-4-phenyl-5- (1-phenyl-1H-tetrazol-5-yl) -pyrimidine (V, R 1 = R 2 = Ph, R 3 = Me)
2-Methyl-5'(1-(4-methyl-phenyl)-1 H-tetrazol-5-yl|-4-phenyl-pyrimidin (V, R1 = 4-Me-C8H4, R2 = Ph, R3 = Me)2-Methyl-5 '(1- (4-methyl-phenyl) -1H-tetrazol-5-yl-4-phenyl-pyrimidine (V, R 1 = 4-Me-C 8 H 4 , R 2 = ph, R 3 = Me)
5-(1-(4-Methoxy-phenyl)-1 H-tetrazol-5-yl]-2-methyl-4-phenyl-pyrim!d!n (V, R1 = 4-MeO-CjH4, R2 = Ph, R3 = Me)5- (1- (4-methoxy-phenyl) -1 H-tetrazol-5-yl] -2-methyl-4-phenyl-pyrim! D! N (V, R 1 = 4-MeO-CJH 4, R 2 = Ph, R 3 = Me)
5-|1-(4-Chlor-phenyl)-1 H-tetrazol-5-yll-2-methyl-4-phenyl-pyrimldin (V, R1 = 4-CI-C8H4, R2 = Ph, R3 » Me)5- | 1- (4-chloro-phenyl) -1 H-tetrazol-5-yll-2-methyl-4-phenyl-pyrimldin (V, R 1 = 4-CI-C 8 H 4, R 2 = Ph , R 3 »Me)
5-I1-(4-Brom-phenyl)-1 H-tetrazol-5-yl]-2-methyl-4-phenyl-pyrimidin (V, R1« 4-Br-C8H4, R2 = Ph, R3 = Me)5-I1- (4-Bromo-phenyl) -1H-tetrazol-5-yl] -2-methyl-4-phenyl-pyrimidine (V, R 1 -4-Br-C 8 H 4 , R 2 = Ph , R 3 = Me)
4-Methyl-2-phenyl-5-(1-phenyM H-tetrazol-5-yl)-pyrimidin (V, R1 = R3 = Ph, R2 = Me) 2,15g dOmmol) 5-(2-Dimethylamino-vinyl)-1-phenyl-1 H-tetrazol (I, R1 = Ph) werden gemäß Beispiel 1 in 5ml absol. Acetonitril undO,95g(12mmol) trockenem Pyridin mit 0,94g(12mmol) Acetylchlorid (II, R2 = Me, X = Cl) zum Zwischenprodukt III, R1 - Ph,4-Methyl-2-phenyl-5- (1-phenyl-H-tetrazol-5-yl) -pyrimidine (V, R 1 = R 3 = Ph, R 2 = Me) 2.15g dOmmol) 5- (2- Dimethylamino-vinyl) -1-phenyl-1 H-tetrazole (I, R 1 = Ph) are in accordance with Example 1 in 5ml absol. Acetonitrile and O, 95g (12 mmol) of dry pyridine with 0.94 g (12 mmol) of acetyl chloride (II, R 2 = Me, X = Cl) to give the intermediate III, R 1 - Ph,
dessen Abscheidung durch weitere Wasserzugabe vervollständigt wird. Nach dem Absaugen, Waschen mit Wasser undwhose deposition is completed by further addition of water. After aspirating, washing with water and
4-Methyl-5-[1-(4-methyl-phenyl)-1-H-tetrazol-5-yll-2-phenyl-pyrimldin (V, R1 = 4-Me-C8H4, R2 =· Me, R3 = Ph)4-Methyl-5- [1- (4-methylphenyl) -1-H-tetrazol-5-yl-2-phenyl-pyrimidine (V, R 1 = 4-Me-C 8 H 4 , R 2 = Me, R 3 = Ph)
5-[1-(4-Fluor-phenyl)-1 H-tetrazol-5-yll-4-methyl-2-phenyl-pyrimidin (V, R' = 4-F-C8H4, R2 = Me, R3 = Ph)5- [1- (4-Fluoro-phenyl) -1H-tetrazol-5-yl-4-methyl-2-phenyl-pyrimidine (V, R '= 4-FC 8 H 4 , R 2 = Me, R 3 = Ph)
2,4-Dlphenyl-5-(1-phenyM H-tetrazol-5-yl)-pyrlmidin (V, R1 - R1 - R3 = Ph)2,4-Dlphenyl-5- (1-phenylm H-tetrazol-5-yl) -pyrlmidine (V, R 1 - R 1 - R 3 = Ph)
5-[1-(4-Methyl-phenyl)-1 H-tetrazol-5-yl]-2,4-dlphenyl-pyrimidin (V, R1 = 4-Me-C8H4, R2 = R3 = Ph)5- [1- (4-Methyl-phenyl) -1H-tetrazol-5-yl] -2,4-dl-phenyl-pyrimidine (V, R 1 = 4-Me-C 8 H 4 , R 2 = R 3 = Ph)
5-|1-(4-Ethyl-phenyl)-1 H-tetrazol-5-ylJ-2,4-diphenyl-pyrlmldin (V, R1 = 4-Et-C8H4, R2 = R3 = Ph)5- | 1- (4-ethyl-phenyl) -1H-tetrazol-5-ylJ-2,4-diphenyl-pyrimidine (V, R 1 = 4-Et-C 8 H 4 , R 2 = R 3 = Ph)
5-[1-(4-Methoxy-phenyl)-1 H-tetrazol-5-yl)-2,4-diphenyl-pyrlmidin (V, R1 = 4-MeO-C8H4, R2 = R3 = Ph)5- [1- (4-Methoxy-phenyl) -1H-tetrazol-5-yl) -2,4-diphenyl-pyrimidine (V, R 1 = 4-MeO-C 8 H 4 , R 2 = R 3 = Ph)
5-[1-(4-Fluor-phenyl)-1 H-tetrazol-5-yl)-2,4-diphenyl-pyrimidin (V, R1 = 4-F-C8H4, R2 = R3 = Ph)5- [1- (4-Fluoro-phenyl) -1H-tetrazol-5-yl) -2,4-diphenyl-pyrimidine (V, R 1 = 4-FC 8 H 4 , R 2 = R 3 = Ph )
FormeIseiteFormeIseite
H3CH 3 C
H3CH 3 C
N-CH=CHN-CH = CH
+ R2COX+ R 2 COX
-HX-HX
H3C,H 3 C,
H3CH 3 C
COR2 N-CH=CCOR 2 N-CH = C
,1,1
+ r3-C*+ r3-C *
IVIV
NH NH· -(CH3J2NH, -H2ONH NH · - (CH 3 J 2 NH, -H 2 O
R1 R 1
ρ i1· Π ι- 7 4ρ i 1 · Π ι- 7 4
Claims (1)
Für andere Tetrazoly!pyrimidine wurden In der Literatur folgende Herstellungsverfahren beschrieben:Tetrazolyl-substituted pyrimidine derivatives of the formula V are hitherto unknown (see FR BENSON, Chem. Rev. 41 [1947] 1; FRBENSON in "Heterocyclic Compounds" [Ed. RC Elderfieldj, Vol. 8, p.1, Wiley, New York, Vol. RN BUTLER, Adv. Heterocycl Chem 21 [1977] 324; RN BUTLER in "Comprehensive Heterocyclic Chemistry" [Hrsg. AR Katritzky and CW Rees), Vol. 5, Part 4 A, p. 791, Pergamon Press, Oxford, 1984).
For other tetrazolypyrimidines, the following production methods have been described in the literature:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD34061090A DD294255A5 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR PREPARING TETRAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD34061090A DD294255A5 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR PREPARING TETRAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD294255A5 true DD294255A5 (en) | 1991-09-26 |
Family
ID=5618453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD34061090A DD294255A5 (en) | 1990-05-14 | 1990-05-14 | PROCESS FOR PREPARING TETRAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD294255A5 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035639A1 (en) * | 2001-10-22 | 2003-05-01 | Eisai Co., Ltd. | Pyrimidine compound and medicinal composition thereof |
| WO2009007187A1 (en) * | 2007-07-09 | 2009-01-15 | Basf Se | Substituted 5-hetarylpyrimidines |
| US8470812B2 (en) | 2009-12-30 | 2013-06-25 | Arqule, Inc. | Substituted benzo-pyrimido-tetrazolo-diazepine compounds |
| US9126973B2 (en) | 2008-09-22 | 2015-09-08 | Cayman Chemical Company, Incorporated | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| CN107778262A (en) * | 2016-08-24 | 2018-03-09 | 尹玉新 | 1,5 disubstituted tetrazole compounds and its preparation method and application |
-
1990
- 1990-05-14 DD DD34061090A patent/DD294255A5/en not_active IP Right Cessation
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035639A1 (en) * | 2001-10-22 | 2003-05-01 | Eisai Co., Ltd. | Pyrimidine compound and medicinal composition thereof |
| US7396836B2 (en) | 2001-10-22 | 2008-07-08 | Eisai R&D Management Co., Ltd. | Pyrimidine compound and medicinal composition thereof |
| WO2009007187A1 (en) * | 2007-07-09 | 2009-01-15 | Basf Se | Substituted 5-hetarylpyrimidines |
| US9126973B2 (en) | 2008-09-22 | 2015-09-08 | Cayman Chemical Company, Incorporated | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| US8470812B2 (en) | 2009-12-30 | 2013-06-25 | Arqule, Inc. | Substituted benzo-pyrimido-tetrazolo-diazepine compounds |
| CN107778262A (en) * | 2016-08-24 | 2018-03-09 | 尹玉新 | 1,5 disubstituted tetrazole compounds and its preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69603240T2 (en) | NEW DEAZAPORE DERIVATIVES; A NEW CLASS OF CRF1-SPECIFIC LIGANDS | |
| DE60319269T2 (en) | Pharmaceutical Use of 2-Substituted 4-Heteroaryl Pyrimidine | |
| DE69208263T2 (en) | SUBSTITUTED AMINOPYRIMIDINE AS ANGIOTENSIN II ANTAGONISTS | |
| DE69013112T2 (en) | PYRIMIDINE DERIVATIVES. | |
| EP1418176B1 (en) | Pyrazole derivates, their preparation and their use in drugs | |
| DE69430988T2 (en) | PYRAZOLOTRIAZINE WITH INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR INHIBITOR EFFECT | |
| DE69410121T2 (en) | DIHYDRO PYRAZOLOPYRROLE | |
| SE457081B (en) | 1,2-DIAMINOCYCLOBUTAN-3,4-DIONES, PROCEDURES FOR PREPARING THESE, INTERMEDIATE AND A PHARMACEUTICAL COMPOSITION | |
| DE60220771T2 (en) | INHIBITORS OF CYCLINE-DEPENDENT KINASES AS AGENTS AGAINST CANCER | |
| DE2147794A1 (en) | New triazoles and preparations containing them | |
| AT503591A2 (en) | ADENOSINE A3 RECEPTOR MODULATORS | |
| CH660484A5 (en) | 4 - ((2,5-PYRROLIDINDION-1-YL) ALKYL) PIPERAZINE COMPOUNDS SUBSTITUTED IN 1-POSITION BY A HETEROCYCLIC REST. | |
| DE3141063A1 (en) | NEW IMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| CH651300A5 (en) | HETEROCYCLICALLY SUBSTITUTED AMINOPROPENNITRILE. | |
| DD155520A5 (en) | PROCESS FOR THE PREPARATION OF CEPHALOSPORIN DERIVATIVES | |
| EP0122580A1 (en) | Pyrimidine derivatives, their preparation and pharmaceutical compositions | |
| Lumma Jr et al. | Inhibitors of gastric acid secretion: 3, 4-diamino-1, 2, 5-thiadiazole 1-oxides and 1, 1-dioxides as urea equivalents in a series of histamine H2 receptor antagonists | |
| Hashem et al. | Synthesis and reactions of some 2 (3h) and 2 (5h) furanone derivatives: a comparative study | |
| DE1946315A1 (en) | New heterocyclic compounds | |
| DE69330593T2 (en) | Heterocyclic compounds with angiotensin II antagonistic activity and their application | |
| DD202552A5 (en) | HETEROCYCLIC DERIVATIVES | |
| DE3618724C2 (en) | N- [3- (Nitro) -quinol-4-yl] carboxamidinamides, process for their preparation and medicaments containing these compounds | |
| DE1909110A1 (en) | Process for the preparation of new heterocyclic compounds | |
| DE68911944T2 (en) | Cardiotonic alkanoyl and aroyloxazoles. | |
| DE2109577A1 (en) | Antimicrobial Nitrofuran Derivatives and Process for the Production of the Same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NPI | Change in the person, name or address of the patentee (addendum to changes before extension act) | ||
| ENJ | Ceased due to non-payment of renewal fee |